Introduction
Participating Members of the European Parliament
MEP Maria Da Graça Carvalho, Former Senior Advisor of Commissioner for Research, Science and Innovation
MEP Susanna Ceccardi, Committee on Foreign Affairs
MEP Tomislav Sokol, Committee on the Internal Market and Consumer Protection SANT, Subcommittee on Public Health
MEP Aldo Patriciello, Committee on Industry, Research and Energy
Programme
Welcome Opening:
MEP Maria Da Graça Carvalho, Member of the European Parliament, Former Senior Advisor of Commissioner for Research, Science and Innovation
Mart-Jan Blauwhoff, Nuclear Medicine Europe President
Introduction
Leo Cendrowicz, Moderator, Editor of the Brussels Time Magazine
“How Nuclear Medicine changed my Conditions”
Patient testimonial with his physician, Prof. Dr med. Axel Rominger, Director of Nuclear Medicine department, Inselspital, Bern
“Advancements in Molecular Imaging”
Dr Antonis Kalemis, PhD., Head of Collaborations & Physics, Molecular Imaging, EMEA, Siemens Healthineers
and
Prof. Dr med. Axel Rominger, Director of Nuclear Medicine Department, Inselspital, Bern
A message by MEP Susanna Ceccardi, Committee on Foreign Affairs
“Clinical Research in Nuclear Medicine and Radioligand Therapy”
Dr med. Germo Gericke, Chief Medical Officer and Head of Research and Development, Ariceum, Germany
“The Radioisotopes Industry facing the Challenge of Theragnostics: Big Efforts for small Drugs”
Dr med. Jean Bonnet MBA, Head of Strategy, IRE Belgium
A message by MEP Tomislav Sokol, Committee on the Internal Market and Consumer Protection SANT, Subcommittee on Public Health
“The Needs for Patient Care and Academic Research”
Prof. Dr Wim J.G. Oyen, Professor of Diagnostic Imaging & Radiotherapy (Humanitas University, Milan,I), Nuclear Medicine Physician (Rijnstate,Arnhem,NL). Chair EANM Policy & Regulatory Affairs Committee
“Timely Access to Nuclear Medicine: a MUST for EU cancer patients”
Prof. Francesco De Lorenzo, President ECPC
“EU Research for Patient Impact”
Dr Margarida Goulard de Medeiros, EU JRC – Head of Unit
“Radiopharmaceuticals are “special”:
Dr med. Konrade von Bremen, CEO Swan Isotopen
Closing by MEP Aldo Patriciello, Committee on Industry, Research and Energy